Cornerstone Capital Management Holdings’s Harvard Bioscience HBIO Stock Holding History

Cornerstone Capital Management Holdings’s Portfolio HBIO Stock Details HBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-6,775	Closed	-$194K	–	1405
2016 Q2	$194K	Sell	6,775 -1,430	-17%	-$45.5K	﹤0.01%	1198
2016 Q1	$248K	Sell	8,205 -1,440	-15%	-$40.8K	﹤0.01%	1175
2015 Q4	$335K	Buy	9,645 +7,685	+392%	+$263K	﹤0.01%	1111
2015 Q3	$74K	Buy	+1,960	New	+$91.2K	﹤0.01%	1367
2014 Q2	–	Sell	-1,490	Closed	-$71K	–	1341
2014 Q1	$71K	Sell	1,490 -380	-20%	-$17.3K	﹤0.01%	1227
2013 Q4	$87K	Sell	1,870 -2,733	-59%	-$119K	﹤0.01%	1123
2013 Q3	$184K	Sell	4,603 -1,135	-20%	-$44.6K	﹤0.01%	1062
2013 Q2	$205K	Buy	+5,738	New	+$220K	﹤0.01%	1045

Other funds holding HBIO

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

JAM

Jupiter Asset Management London, United Kingdom $18.8B AUM 29.2% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Cornerstone Capital Management Holdings's HBIO Position: Q3 2016 in Review

Cornerstone Capital Management Holdings sold out of Harvard Bioscience (HBIO) in Q3 2016, closing a stake of 6,775 shares — an estimated $194K sold.

Cornerstone Capital Management Holdings first reported a position in HBIO in Q2 2013 and held it in 8 quarters. The position peaked at $335K in Q4 2015. 69 funds tracked by Wall St. Rank hold HBIO as of Q3 2016.

Cornerstone Capital Management Holdings reported no remaining Harvard Bioscience position as of Q3 2016 after selling out during the quarter.
Cornerstone Capital Management Holdings sold 6,775 Harvard Bioscience shares in Q3 2016, an estimated $194K.
Cornerstone Capital Management Holdings first reported a position in Harvard Bioscience in Q2 2013 and held it in 8 quarters.
Cornerstone Capital Management Holdings's Harvard Bioscience position peaked at $335K in Q4 2015.
69 funds tracked by Wall St. Rank held Harvard Bioscience as of Q3 2016.

Based on Cornerstone Capital Management Holdings's 13F filing for Q3 2016, filed 16 Nov 2016.